Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals-Reference-Cited by-同舟云学术

Post-treatment fibrotic modifications overwhelm pretreatment liver fibrosis in predicting HCC in CHC patients with curative antivirals

Published:2018-11 Issue:6 Volume:12 Page:544-551
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Huang Chung-Feng,Yeh Ming-Lun,Huang Ching-I,Liang Po-Cheng,Lin Yi-Hung,Lin Zu-Yau,Chen Shinn-Cherng,Huang Jee-Fu,Dai Chia-Yen,Chuang Wan-Long,Yu Ming-Lung

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/article/10.1007/s12072-018-9908-4/fulltext.html

Reference30 articles.

1. Blach S, Zeuzem S, Manns M, Altraif I, Duberg AS, Muljono DH, Waked I, Alavian SM, Lee MH, Negro F, Abaalkhail F. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2017;2(3):161–176

2. MohdHanafiah K, Groeger J, Flaxman AD, et al. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (Baltimore, Md.) 2013;57(4):1333–1342

3. Davila JA, Morgan RO, Shaib Y, et al. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 2004;127(5):1372–1380

4. Huang CF, Yeh ML, Huang CI, et al. Risk of hepatitis C virus related hepatocellular carcinoma between subjects with spontaneous and treatment-induced viral clearance. Oncotarget 2017;8(27):43925–43933

5. Huang CF, Yeh ML, Huang CY, et al. Pretreatment glucose status determines HCC development in HCV patients with mild liver disease after curative antiviral therapy. Medicine 2016;95(27):e4157

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication;Clinical and Molecular Hepatology;2024-07-01

2. Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy;Clinical and Molecular Hepatology;2024-07-01

3. Liver stiffness and spleen stiffness predict distinct liver-related events after hepatitis C eradication with direct-acting antivirals;Journal of the Formosan Medical Association;2024-03

4. Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review;Clinical Infectious Diseases;2023-08-14

5. Dynamic personalized prediction of the individual liver‐related risk after sustained viral response in HCV patients;Journal of Viral Hepatitis;2023-03-31